Headache Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial (video)
Creator
Deborah I. Friedman, MD, MPH; Peter Quiros; Prem S. Subramanian, MD, PhD; Luis Mejico, Michael McDermott
Affiliation
(DIF) University of Texas Southwestern; (PSS) University of Colorado
Subject
High Intracranial Pressure/Headache; Pseudotumor Cerebri
Description
Headache is the most common symptom of IIH. The IIHTT prospectively enrolled 165 participants with mild visual field loss to assess whether acetazolamide (ACZ) plus dietary management was superior to placebo (PBO) tablets plus dietary management in improving visual function [1]. We report the headache outcomes of participants in the IIHTT.
Date
2017
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2017 North American Neuro-Ophthalmology Society Annual Meeting